Summary
Brain edema is associated with a variety of neuropathological conditions such as brain trauma, ischemic and hypoxic brain injury, central nervous system infection, acute attacks of multiple sclerosis, and brain tumors. A common finding is an inflammatory response, which may have a significant impact on brain edema formation. One critical event in the development of brain edema is blood-brain barrier (BBB) breakdown, which may be initiated and regulated by several proinflammatory mediators (oxidative mediators, adhesion molecules, cytokines, chemokines). These mediators not only regulate the magnitude of leukocyte extravasation into brain parenchyma, but also act directly on brain endothelial cells causing the loosening of junction complexes between endothelial cells, increasing brain endothelial barrier permeability, and causing vasogenic edema. Here we review junction structure at the BBB, the effects of pro-inflammatory mediators on that structure, and focus on the effects of chemokines at the BBB. New evidence indicates that chemokines (chemoattractant cytokines) do not merely direct leukocytes to areas of injury. They also have direct and indirect effects on the BBB leading to BBB disruption, facilitating entry of leukocytes into brain, and inducing vasogenic brain edema formation. Chemokine inhibition may be a new therapeutic target to reduce vasogenic brain edema.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Andjelkovic AV, Kerkovich D, Shanley J, Pulliam L, Pachter JS (1999) Expression of binding sites for β chemokines on human astrocytes. Glia 28: 225–235
Andjelkovic AV, Spencer DD, Pachter JS (1999) Visualization of chemokine binding sites on human brain microvessels. J Cell Biol 145: 401–413
Anthony D, Dempster R, Fearn S, Clements J, Wells G, Perry VH, Walker K (1998) CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol 8: 923–926
Bauer HC, Bauer H (1999) Neural induction of the blood brain barrier: still an enigma. Cell Mol Neurobiol 20: 13–28
Blamire AM, Anthony DC, Rajagopalan B, Sibson NR, Perry VH, Styles P (2000) Interleukin-1beta-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci 20: 8153–8159
Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, Loc PP, Phu NH, Bethell D, Farrar J, Gatter K, White N, Turner G (1999) Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 25: 331–340
Campbell SJ, Wilcockson DC, Butchart AG, Perry VH, Anthony DC (2002) Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J Neurochem 83: 432–441
Chen Y, Hallenbeck JM, Ruetzler C, Bol D, Thomas K, Berman NE, Vogel SN (2003) Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 23: 748–755
Citi S, Cordenonsi M (1998) Tight junction proteins. Biochim Biophys Acta 1448: 1–11
Coghlan MP, Chou MM, Carpenter CL (2000) Atypical protein kinases C-λ and-ζ associate with the GTP-binding protein Cdc42 and mediate stress fiber loss. Mol Cell Biol 20: 2880–2889
Couraud PO (1998) Infiltration of inflammatory cells through brain endothelium. Pathol Biol (Paris) 46: 176–180
Davies DC (2002) Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200: 639–646
Denker BM, Nigam SK (1998) Molecular structure and assembly of the tight junction. Am J Physiol 274: F1–F9
Dietrich JB (2002) The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J Neuroimmunol 128: 58–68
Farshori P, Kachar B (1999) Redistribution and phosphorylation of occludin during opening and resealing of tight junctions in cultured epithelial cells. J Membr Biol 170: 147–156
Feuerstein, GZ, Wang X, Barone FC (2000) Inflammatory gene expression in cerebral ischemia and trauma. Ann New York Acad Sci 24: 179
Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH (1999) Early appearance of activated matrix metalloproteinase-9 and blood brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 842: 92–100
Garcia JG, Schaphorst KL (1995) Regulation of endothelial cell gap formation and paracellular permeability. J Invest Med 43: 117–126
Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A, Fisher M, Kaps M, Bachmann G (2004) Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 35: 566–571
Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K (2001) Molecular and cellular permeability control at the blood brain barrier. Brain Res Brain Res Rev 36: 258–264
Gray F, Belec L, Chretien F, Dubreuil-Lemaire ML, Ricolfi F, Wingertsmann L, Poron F, Gherardi R (1998) Acute, relapsing brain oedema with diffuse blood-brain barrier alteration and axonal damage in the acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 24: 209–216
Halliday G, Robinson SR, Shepherd C, Kril J (2000) Alzheimer’s disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 27: 1–8
Heo JH, Han SW, Lee SK (2005) Free radicals as triggers of brain edema formation after stroke. Free Radic Biol Med 39: 51–70
Hosomi N, Ban CR, Naya T, Takahashi T, Guo P, Song XY, Kohno M (2005) Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J Cereb Blood Flow Metab 25: 959–967
Huber JD, Egleton RD, Davis TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24: 719–725
Kirk J, Plumb J, Mirakhur M, McQuaid S (2003) Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 201: 319–327
Koedel U, Pfister HW (1999) Oxidative stress in bacterial meningitis. Brain Pathol 9: 57–67
Kumai Y, Ooboshi H, Takada J, Kamouchi M, Kitazono T, Egashira K, Ibayashi S, Iida M (2004) Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats. J Cereb Blood Flow Metab 24: 1359–1368
Lorenzl S, Koedel U, Pfister HW (1996) Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat. Crit Care Med 24: 1874–1880
Losy J, Zaremba J (2001) Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 32: 2695–2696
Mark KS, Davis TP (2002) Cerebral microvascular changes in permeability and tight junctions induced by hypoxiareoxygenation. Am J Physiol 282: H1485–H1494
Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, Simmons D, Dejana E (1998) Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. Cell Biol 142: 117–127
Martiney JA, Cuff C, Litwak M, Berman J, Brosnan CF (1998) Cytokine-induced inflammation in the central nervous system revisited. Neurochem Res 23: 349–356
Mastroianni CM, Lancella L, Mengoni F, Lichtner M, Santopadre P, D’Agostino C, Ticca F, Vullo V (1998) Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyrogenic and tuberculous meningitis. Clin Exp Immunol 114: 210–214
Matsumoto T, Ikeda K, Mukaida N, Harada A, Matsumoto Y, Yamashita J, Matsushima K (1997) Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 77: 119–125
Mellado M, Rodriguez-Frade JM, Manes S, Martinez-A C (2001) Chemokine signaling and functional responses: the role of receptors dimerization and TK pathway activation. Ann Rev Immunol 19: 397–421
Menicken F, Maki R, de Souza EB, Quirion R (1999) Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci 20: 73–77
Merrill JE, Murphy SP (1997) Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain Behav Immun 11: 245–263
Miller RJ, Meucci O (1999) AIDS and the brain: is there a chemokine connection? Trends Neurosci 22: 471–476
Mitic LL, Aderon JM (1998) Molecular architecture of tight junctions. Ann Rev Physiol 60: 121–142
Murphy PM (1994) The molecular biology of leukocyte chemoattractant receptors. Ann Rev Immunol 12: 593–633
Nagafuchi A (2001) Molecular architecture of adherens junctions. Curr Opin Cell Biol 13: 600–603
Ng I, Yap E, Tan WL, Kong NY (2003) Blood-brain barrier disruption following traumatic brain injury: roles of tight junction proteins. Ann Acad Med Singapore 32: S63–S66
Oprica M, Van Dam AM, Lundkvist J, Iverfeldt K, Winblad B, Bartfai T, Schultzberg M (2004) Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse. Acta Neuropathol (Berl) 108: 69–80
Ozates M, Kemaloglu S, Gurkan F, Ozkan U, Hosoglu S, Simsek MM (2000) CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol 41: 13–17
Paul R, Koedel U, Winkler F, Kieseier BC, Fontana A, Kopf M, Hartung HP, Pfister HW (2003) Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 126: 1873–1882
Petty MA, Lo EH (2002) Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 68: 311–323
Prat A, Biernacki K, Wosik K, Antel JP (2001) Glia cell influence on the human blood brain barrier. Glia 36: 145–155
Reidel MA, Stippich C, Heiland S, Storch-Hagenlocher B, Jansen O, Hahnel S (2003) Differentiation of multiple sclerosis plaques, subacute cerebral ischaemic infarcts, focal vasogenic oedema and lesions of subcortical arteriosclerotic encephalopathy using magnetisation transfer measurements. Neuroradiology 45: 289–294
Ridley AJ (1997) Signaling by rho family proteins. Biochem Soc Trans 25: 1005–1010
Rodriguez-Frade JM, Mellado M, Martinez-A C (2001) CCR2. In: Oppenheim J, Feldmann M, Durum SK (eds) Cytokine reference: a compendium of cytokines and other mediators of host defense, vol 2: receptors. Academic Press, London, pp 2041–2052
Rollins BJ (1997) Chemokines. Blood 90: 909–928
Rubin LL, Staddon JM (1999) The cell biology of the blood-brain barrier. Ann Rev Neurosci 22: 11–28
Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S (1997) Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137: 1393–1401
Schraufstatter IU, Chung J, Burger M (2001) IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol 280: L1094–L1103
Sindern E, Niederkinkhaus Y, Henschel M, Ossege LM, Patzold T, Malin JP (2001) Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand 104: 88–91
Small VJ, Rottner K, Kaverina I (1999) Functional design in the actin cytoskeleton. Curr Opin Cell Biol 11: 54–60
Sorensen TL, Ransohoff RM, Strieter RM, Sellebjerg F (2004) Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur J Neurol 11: 445–449
Staddon JM, Rubin LL (1996) Cell adhesion, cell junctions and the blood-brain barrier. Curr Opin Neurobiol 6: 622–627
Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV (2003) Potential role of MCP-1 in endothelial cell tight junction ‘opening’: signaling via Rho and Rho kinase. J Cell Sci 116: 4615–4628
Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, Andjelkovic AV (2005) Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 25: 593–606
Sutherland JD, Witke W (1999) Molecular genetic approaches to understanding the actin cytoskeleton. Curr Opin Cell Biology 11: 142–151
Tsukamato T, Nigam SK (1999) Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am J Physiol 276: F737–F750
Unterberg AW, Stover J, Kress B, Kiening KL (2004) Edema and brain trauma. Neuroscience 129: 1021–1029
Wachtel M, Frei K, Ehler E, Fontana A, Winterhalter K, Gloor SM (1999) Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci 112: 4347–4356
Wang AJ, Pollard TD, Herman IM (1983) Actin filaments stress fibers in vascular endothelial cells in vivo. Science 219: 867–869
Wolburg H, Risau W (1995) Formation of the blood-brain barrier. In: Kettenmann H, Ransom BR (eds) Neuroglia. Oxford University Press, Oxford, pp 763–776
Yang GY, Gong C, Qin Z, Liu XH, Betz AL (1999) Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res 69: 135–143
Yoshie O, Imai T, Nomiyama H (1997) Novel lymphocytespecific CC chemokines and their receptors. J Leukoc Biol 62: 634–644
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag
About this paper
Cite this paper
Stamatovic, S.M., Dimitrijevic, O.B., Keep, R.F., Andjelkovic, A.V. (2006). Inflammation and brain edema: new insights into the role of chemokines and their receptors. In: Hoff, J.T., Keep, R.F., Xi, G., Hua, Y. (eds) Brain Edema XIII. Acta Neurochirurgica Supplementum, vol 96. Springer, Vienna. https://doi.org/10.1007/3-211-30714-1_91
Download citation
DOI: https://doi.org/10.1007/3-211-30714-1_91
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-30712-0
Online ISBN: 978-3-211-30714-4
eBook Packages: MedicineMedicine (R0)